JPMorgan Chase & Co’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $178M | Buy |
|
|||||
|
2025
Q2 | $126M | Sell |
|
|||||
|
2025
Q1 | $200M | Sell |
|
|||||
|
2024
Q4 | $321M | Sell |
|
|||||
|
2024
Q3 | $1.02B | Buy |
|
|||||
|
2024
Q2 | $1.09B | Sell |
|
|||||
|
2024
Q1 | $1.02B | Sell |
|
|||||
|
2023
Q4 | $1.31B | Buy |
|
|||||
|
2023
Q3 | $1.28B | Buy |
|
|||||
|
2023
Q2 | $1.27B | Buy |
|
|||||
|
2023
Q1 | $1.14B | Buy |
|
|||||
|
2022
Q4 | $629M | Buy |
|
|||||
|
2022
Q3 | $562M | Buy |
|
|||||
|
2022
Q2 | $403M | Sell |
|
|||||
|
2022
Q1 | $458M | Sell |
|
|||||
|
2021
Q4 | $1.09B | Sell |
|
|||||
|
2021
Q3 | $1.59B | Buy |
|
|||||
|
2021
Q2 | $1.85B | Buy |
|
|||||
|
2021
Q1 | $1.09B | Buy |
|
|||||
|
2020
Q4 | $713M | Buy |
|
|||||
|
2020
Q3 | $586M | Buy |
|
|||||
|
2020
Q2 | $531M | Buy |
|
|||||
|
2020
Q1 | $461M | Buy |
|
|||||
|
2019
Q4 | $427M | Buy |
|
|||||
|
2019
Q3 | $216M | Sell |
|
|||||
|
2019
Q2 | $230M | Sell |
|
|||||
|
2019
Q1 | $422M | Sell |
|
|||||
|
2018
Q4 | $803M | Sell |
|
|||||
|
2018
Q3 | $993M | Buy |
|
|||||
|
2018
Q2 | $744M | Sell |
|
|||||
|
2018
Q1 | $841M | Buy |
|
|||||
|
2017
Q4 | $897M | Buy |
|
|||||
|
2017
Q3 | $770M | Buy |
|
|||||
|
2017
Q2 | $618M | Sell |
|
|||||
|
2017
Q1 | $989M | Sell |
|
|||||
|
2016
Q4 | $1.03B | Buy |
|
|||||
|
2016
Q3 | $1.13B | Buy |
|
|||||
|
2016
Q2 | $749M | Sell |
|
|||||
|
2016
Q1 | $985M | Sell |
|
|||||
|
2015
Q4 | $1.32B | Buy |
|
|||||
|
2015
Q3 | $1.15B | Sell |
|
|||||
|
2015
Q2 | $2B | Sell |
|
|||||
|
2015
Q1 | $2.47B | Sell |
|
|||||
|
2014
Q4 | $2.37B | Buy |
|
|||||
|
2014
Q3 | $2.29B | Sell |
|
|||||
|
2014
Q2 | $2.24B | Buy |
|
|||||
|
2014
Q1 | $1.89B | Sell |
|
|||||
|
2013
Q4 | $1.92B | Sell |
|
|||||
|
2013
Q3 | $2.11B | Sell |
|
|||||
|
2013
Q2 | $2.11B | Buy |
|